Table 5
Maternal and neonatal pregnancy outcomes in the two groups
| IDet | NPH | T/ | P value | |
| Maternal pregnancy outcomes | ||||
| Gestational age at delivery (weeks） | 38.64±2.19 | 38.15±3.05 | 1.418 | 0.157 |
| Cesarean section, n (%) | 78 (65.00) | 74 (61.67) | 0.287 | 0.592 |
| Gestational weight gain (kg） | 12.21±3.84 | 11.99±4.11 | 0.618 | 0.662 |
| Hypertension during pregnancy, n (%) | 14 (11.67) | 23 (19.17) | 2.588 | 0.107 |
| Polyhydramnios, n (%) | 10 (8.33) | 8 (6.67) | 0.240 | 0.624 |
| Infection, n (%) | 15 (12.50) | 18 (15.00) | 0.316 | 0.574 |
| Hypoglycemia in pregnant women, n (%) | 14 (11.67) | 28 (23.33) | 5.657 | 0.017 |
| Adverse drug reactions, n (%) | 3 (2.5) | 2 (1.67) | 0.203 | 0.652 |
| Neonatal pregnancy outcomes | ||||
| Congenital anomaly, n (%) | 3 (2.50) | 3 (2.50) | 0.000 | 1.000 |
| Preterm delivery, n (%) | 15 (12.50) | 18 (15.00) | 0.316 | 0.574 |
| Birth weight (g) | 3257.67±496.60 | 3179.75±671.81 | 1.022 | 0.308 |
| Low birth weight, n (%) | 5 (4.17) | 8 (6.67) | 0.732 | 0.392 |
| Macrosomia, n (%) | 10 (8.33) | 10 (8.33) | 0.000 | 1.000 |
| Hyperbilirubinemia, n (%) | 51 (42.50) | 56 (46.67) | 0.422 | 0.516 |
| NRDS, n (%) | 3 (2.50) | 3 (2.50) | 0.000 | 1.000 |
| Neonatal hypoglycemia, n (%) | 5 (4.17) | 10 (8.33) | 1.778 | 0.182 |
| NICU admission, n (%) | 35 (29.17) | 38 (31.67) | 0.177 | 0.674 |
IDet, insulin detemir; NICU, Neonatal intensive care unit; NPH, neutral protamine Hagedorn; NRDS, Neonatal respiratory distress syndrome.